Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy



Status:Completed
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:21 - Any
Updated:4/2/2016
Start Date:May 2011
End Date:May 2012
Contact:Cheryl Swanson, COT
Email:eyes@virdieyemd.com
Phone:3097885524

Use our guide to learn which trials are right for you!

Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)

This study will compare the effect of two topical non-steroidal antiinflammatory agents to
control pain after photorefractive keratectomy (PRK) eye surgery.


Inclusion Criteria:

- male or female at least 18 years of age,

- no other ocular studies with 15 days prior to dosing,

- BCVA 20/200 or better,

- return for study visits and follow instructions from investigator and staff,

- self administer test article

Exclusion Criteria:

- Ocular inflammation,

- hypersensitivity to bromfenac or nepafenac,

- any corneal pathology,

- have had radial keratotomy,

- corneal transplant or corneal refractive surgery in the last two years
We found this trial at
1
site
Rock Island, Illinois 61201
464
mi
from
Rock Island, IL
Click here to add this to my saved trials